Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epilepsy
epilepsy
Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD
BioMedReports
Sat, 01/7/12 - 02:34 pm
Supernus Pharmaceuticals
SPN-538
SPN-810
SPN-812
ADHD
epilepsy
FDA approves Lundbeck's Onfi for LGS
Pharma Times
Tue, 10/25/11 - 06:32 pm
Lundbeck
LGS
FDA
Onfi
epilepsy
Pfizer Stops Epilepsy Drug Trial as Efficacy Proved
Bloomberg
Sat, 10/8/11 - 11:55 am
Pfizer
Lyrica
epilepsy
Pfizer Stops Trial of Epilepsy Drug Lyrica as Efficacy Proved
Bloomberg
Thu, 10/6/11 - 09:24 am
Pfizer
Lyrica
epilepsy
ViroPharma receives European Union approval for pediatric epileptic seizure treatment
Yahoo/AP
Wed, 09/7/11 - 09:45 am
Europe
ViroPharma
epilepsy
Are Two FDA Approvals in One Week a Positive Sign?
Motley Fool
Thu, 06/16/11 - 10:12 pm
FDA
Nulojix
kidney transplant
Bristol-Myers Squibb
GSK
Valeant Pharmaceuticals
Potiga
epilepsy
UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
NY Times, NY
Thu, 06/9/11 - 10:49 pm
UCB Pharmaceuticals
Keppra
epilepsy
off-label
Lundbeck Wants To Stop US Prisons Getting Epilepsy Drug
WSJ Online
Wed, 06/8/11 - 08:56 am
epilepsy
Lundbeck
execution drugs
Pfizer Blames Teva, Ivax for ’Billions’ in Neurontin Losses
Bloomberg
Wed, 05/18/11 - 11:36 am
Ivax Diagnostics
Teva Pharmaceuticals
Neurontin
Pfizer
generics
epilepsy
Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tue, 05/17/11 - 08:53 pm
Vivus
epilepsy
Qnexa
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
PharmaLive
Sat, 04/23/11 - 11:06 am
GSK
Valeant Pharmaceuticals
ezogabine
epilepsy
Valeant Pharmaceuticals, GlaxoSmithKline respond to FDA request on epilepsy drug
Yahoo/AP
Mon, 04/18/11 - 11:10 am
GSK
Valeant Pharmaceuticals
FDA
epilepsy
ezogabine
Vertex epilepsy drug meets key midstage study goal
Yahoo/AP
Thu, 03/10/11 - 06:02 pm
epilepsy
Vertex Pharmaceuticals
VX-765
FDA warns of birth defects with Topamax
Yahoo/AP
Fri, 03/4/11 - 10:33 am
FDA
Topamax
epilepsy
birth defects
Natus Medical Appoints John T. Buhler as President and COO
Wed, 02/9/11 - 04:12 pm
Natus Medical
CEO
neurological dysfunction
epilepsy
sleep disorders
newborn care
hearing impairment
Boost for VRX-GSK Epilepsy Drug
Yahoo/Zacks.com
Tue, 01/25/11 - 11:07 am
epilepsy
GSK
JNJ
Pfizer
Valeant Pharmaceuticals
Europe
retigabine
Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
BusinessWire
Sun, 12/5/10 - 12:11 pm
Lennox-Gastaut Syndrome
epilepsy
clobazam
Lundbeck
Valeant, GSK Prepare for Approval of Anti-Epileptic Drug Despite Latest Delay
Seeking Alpha
Sun, 12/5/10 - 11:53 am
Valeant Pharmaceuticals
GSK
epilepsy
Potiga
Setback for Valeant Epilepsy Drug
Yahoo/Zacks
Sat, 12/4/10 - 12:18 pm
Valeant Pharmaceuticals
epilepsy
ezogabine
GSK
Cyberonics Confirms Safety and Efficacy of VNS Therapy
Fri, 11/5/10 - 12:52 pm
Cyberonics
VNS Therapy System
epilepsy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »